The presentation, treatment and outcome of renal cell carcinoma in old age

被引:10
作者
Doherty, JG [1 ]
Rüfer, A [1 ]
Bartholomew, P [1 ]
Beaumont, DM [1 ]
机构
[1] Queen Elizabeth Hosp, Dept Geriatr Med, Sheriff Hill NE9 6SX, Gateshead, England
关键词
age; erythrocyte sedimentation rate; clinical presentation; renal cell carcinoma;
D O I
10.1093/ageing/28.4.359
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objective: to review clinical presentation and outcome of patients with a diagnosis of renal cell carcinoma at a district general hospital and assess whether older patients were more likely to present in a non-specific manner or receive more conservative management and whether their survival was less favourable. Subjects and methods: 39 patients presenting with a diagnosis of renal cell carcinoma between 1987 and 1995 were identified from hospital activity analysis data and histopathology records. We divided the subjects into young patients (<69 years: n = 27) and elderly patients (>70 years: n = 10), and made a retrospective analysis of clinical features, laboratory results, pathology, staging, treatment and survival from hospital records. Results: anaemia, hypertension and weight loss were common clinical features in both young and elderly groups. The prevalence of non-urological symptoms did not differ between study groups. Anaemia was frequently microcytic and hypochromic. Hypertension was present in 46% of patients and one-third of these were newly diagnosed. In 19% of patients with renal cell carcinoma, the diagnosis was made incidentally while imaging for other indications. Elderly patients were as likely to receive surgical treatment as younger patients. Survival differed with stage but not age. Conclusions: neither clinical presentation, management nor survival differed between the young and elderly subjects. Renal cell carcinoma should be considered in elderly patients with systemic features such as malaise or weight loss associated with anaemia, hypertension and raised erythrocyte sedimentation rate.
引用
收藏
页码:359 / 362
页数:4
相关论文
共 22 条
[1]  
*AM CANC SOC, 1994, CA CANC FACTS FIG
[2]  
[Anonymous], PRINCIPLES PRACTICES
[3]  
CHERUKURI S V, 1977, Urology, V10, P93, DOI 10.1016/0090-4295(77)90001-2
[4]   HYPERNEPHROMA - GREAT IMITATOR [J].
EWERT, EE ;
PIRES, EM ;
CONCEPCION, RL .
MEDICAL CLINICS OF NORTH AMERICA, 1963, 47 (02) :431-&
[5]  
GOMEZ JM, 1987, RENAL FUNCTION DIS E, P400
[6]  
Hocking W G, 1987, Hematol Oncol Clin North Am, V1, P229
[7]   HYPERNEPHROMA - INTERNISTS TUMOR [J].
KIELY, JM .
MEDICAL CLINICS OF NORTH AMERICA, 1966, 50 (04) :1067-&
[8]  
KIRSCHNER FK, 1976, J UROLOGY, V115, P643
[9]   RENAL-CELL CARCINOMA AS AN INCIDENTAL FINDING [J].
KONNAK, JW ;
GROSSMAN, HB .
JOURNAL OF UROLOGY, 1985, 134 (06) :1094-1096
[10]   MICROCYTIC HYPOCHROMIC-ANEMIA ASSOCIATED WITH RENAL-CELL CARCINOMA [J].
KROLL, MH ;
JIJI, V ;
JIJI, R .
SOUTHERN MEDICAL JOURNAL, 1984, 77 (05) :635-637